What’s in a vaccine? Protecting cats against common infectious…

Presented by Kelly St. Denis, MSc, DVM, Dipl. ABVP (feline)

Continuing education questionnaire

CE credit: 1

AssignedWebcast

Name

First name *

Last name *

License number *

Province where you practise *

Email *

Questions

1. Core infectious disease agents which all cats should be vaccinated against include: *

Chlamydia felis

Feline herpesvirus-1

Feline immunodeficiency virus

Bordetella bronchiseptica

2. The outcomes of infection with feline leukemia virus (FeLV) include: *

Abortive, latent and regressive infections

Acute phase, asymptomatic phase and clinical phase

Acute and chronic infections

Abortive, regressive and progressive infections

3. True or False. The FeLV status of a patient is static and easy to determine. *

True

False

4. When a patient from a multicat household tests positive for FeLV p27 antigen on a point-of-care test, the next step is to: *

Recommend euthanasia

Proceed with secondary testing to confirm infection

Proceed with vaccination against FeLV

Allow the cat to continue living with its housemates, since it’s not infectious

5. Understanding vaccine design is important to: *

Choose the right vaccine for the patient

Understand potential side effects

Understand expected efficacy

All of the above

6. Which of the following statements is incorrect? Adjuvants: *

Are useful in certain vaccinations to improve the immune response

Have been directly incriminated in the development of feline vaccine injection site sarcomas

Include aluminum, complete Freund’s adjuvant, lipids and saponin-based adjuvants

Stimulate the humoral arm of the immune system

7. Recombinant vaccines: *

Almost always contain adjuvants

Are dangerous because they splice genetic material into the cat’s own DNA

Are safe and effective for targeted infectious agents

Replicate in the cat, and may cause mild disease side effects

8. Feline injection site sarcomas: *

Are most commonly associated with vaccination

Have been reported in literature that potentially associate with other injections including meloxicam, microchips and some depot/slow release drugs

Have decreased in incidence since the advent of a non-adjuvanted FeLV vaccine

All of the above

9. The American Association of Feline Practitioners recommends specific injection sites for vaccines according to the following directions: *

All vaccinations should be administered subcutaneously in the scruff

Feline viral rhinotracheitis, calicivirus and panleukopenia (FVRCP) in the right front limb; rabies in the right hindlimb; FeLV vaccine in the left hindlimb

All vaccinations should be administered subcutaneously and low in the designated limb; below the elbow for the forelimb and below the stifle for the hindlimb

b and c

10. If a patient develops a suspected vaccine-related swelling or mass: *

The mass should be biopsied by fine needle aspiration (FNA) and incisional biopsy if it persists for 3 months, enlarges more than 2 cm at any time or continues to increase in size 1 month after injection

Immediate excisional removal is recommended

The mass isn’t likely an issue and does not require monitoring

The mass should be monitored according to the 5-6-7-8 rule